Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA in India

This article was originally published in The Tan Sheet

Executive Summary

HHS Secretary Michael Leavitt and FDA Commissioner Andrew von Eschenbach are organizing teams to help advise the Indian government in creating its equivalent to FDA, Leavitt says Jan. 7 in a post to his blog. Leavitt offered the Indian Minister of Health and Family Welfare, Anbumani Ramadoss, technical assistance and discussed food and drug safety, he says. In September 2007, von Eschenbach worked with Chinese officials to finalize a memorandum on food, drug and medical device safety (1"The Tan Sheet" Sept. 24, 2007, In Brief)...

You may also be interested in...



India Looks To Model New Central Drug Authority After U.S. FDA

NEW DELHI - With elections to parliament slated for next year, India's Congress Party-led government is expected to pass a slew of bills in the pharmaceutical sector soon, including one establishing a central drug authority

Dr. Reddy’s wins generic Zantac approval

FDA approves Dr. Reddy's Laboratories abbreviated new drug application to manufacture and market generic OTC versions of ranitidine 150 mg tablets acid indigestion treatment (GlaxoSmithKline's Zantac), Dr. Reddy's announces Sept. 13. The Hyderabad, India-based drug firm says the approval marks its first U.S. drug approval since it unveiled plans in May to launch a store-brand OTC business unit in the country. The firm is set to expand its OTC product portfolio and additional product introductions in the coming months which will include Rx switches and select OTC monograph products, the firm's North American Generics President Mark Hartman said...

Cosmetic And Personal Care Trademark Review: 16 April

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS101247

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel